Those prognosticator adjustments came a day after Integer published its latest earnings report, in which it posted ...
Integer (NYSE:ITGR) reported fourth-quarter and full-year 2025 results that management said landed toward the high end of the company’s October outlook, while also outlining a 2026 forecast pressured ...
Delivered 8% sales growth and 21% adjusted EPS growth in full year 2025 ~ ~ 2026 Outlook maintains midpoint of sales growth and high end of ...
StockStory.org on MSN
Integer Holdings’s (NYSE:ITGR) Q4 CY2025 sales beat estimates
Medical technology company Integer Holdings (NYSE:ITGR) reported in Q4 CY2025, with sales up 5% year on year to $472.1 ...
6don MSN
Integer outlines 2026 organic sales growth of flat to 3% amid headwinds from three new products
Q4 2025 Management View CEO Payman Khales reported that "sales and adjusted EPS towards the high end of the outlook range we provided in October." He stated for the full year, "sales increased 8% on a ...
A live webcast and replay for each event will be accessible under “News & Events” on the Investor Relations section of Integer’s website at investor.integer.net. Learn more about Integer at ...
Shares of Integer (NYSE: ITGR), a company specializing in the development and manufacturing of medical devices, saw a substantial decline of 32% on October 23, 2025. This notable drop was mainly due ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results